Mr. Bloemhard serves as President, Healthcare & Water Technologies of DuPont and is a named executive officer in the Company's 2026 Proxy Statement. He is reported as a named executive officer for the fiscal year ended December 31, 2025.
Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.